Skip to main content

Concurrent Investment Advisors, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 2001015 Tampa, FL

Position in GILD

as of Jun 30, 2026 · filed Jul 27, 2026
Position Value
$10,317,429
-$161,103 QoQ
Shares Held
81,664
+8.6% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#424
of 2,266 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Derivatives in GILD

reported options exposure · as of Sep 30, 2024
CallValue
$8,384
CallShares
100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Concurrent Investment Advisors, LLC holds $273,585,885 across 14 Drug Manufacturers - General names. GILD ranks #8 (3.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 GILD
Gilead Sciences, Inc.
This page
81,664 $10,317,429

All Filings in GILD

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,317,429 81,664
2026-03-31 $10,478,532 75,185
2025-12-31 $8,850,535 72,108
2025-09-30 $6,139,188 55,308
2025-06-30 $5,855,155 52,811
2025-03-31 $4,218,346 37,647
2024-12-31 $2,745,144 29,719
2024-09-30 $2,516,625 30,017
2024-09-30 $8,384 100
2024-06-30 $1,997,237 29,110
2024-06-30 $6,861 100
2024-03-31 $1,944,055 26,540
2024-03-31 $7,325 100
2023-12-31 $2,205,578 27,226